Back to Search
ANGELA MONGE, PH.D
PH.D
Clinical Psychologist
NPI: 1619404043Individual
Specialties, Licenses & Credentials
Clinical PsychologistPrimary
Psychologist — Clinical
Code: 103TC0700X
021814(NY)
Research & Publications (20)
Cytotoxic palladium complexes of bioreductive quinoxaline N1,N4-dioxide prodrugs.
PMID 19162490·Bioorg Med Chem·2009
7-preclinical
QSAR analysis for quinoxaline-2-carboxylate 1,4-di-N-oxides as anti-mycobacterial agents.
PMID 19394254·J Mol Graph Model·2009
8-other
Cytotoxic, mutagenic and genotoxic effects of new anti-T. cruzi 5-phenylethenylbenzofuroxans. Contribution of phase I metabolites on the mutagenicity induction.
PMID 19595752·Toxicol Lett·2009
7-preclinical
Somatostatin and gentamicin-induced auditory hair cell loss.
PMID 19294753·Laryngoscope·2009
7-preclinical
Isolation of enantiomerically pure organometallic palladium compounds: synthesis of the triangles prepared from enantiopure [cis-Pd2(C6H4PPh2)2(NCCH3)4]2+.
PMID 19352527·Dalton Trans·2009
8-other
Selective activity against Mycobacteriumtuberculosis of new quinoxaline 1,4-di-N-oxides.
PMID 19058970·Bioorg Med Chem·2009
8-other
Heterocyclic-2-carboxylic acid (3-cyano-1,4-di-N-oxidequinoxalin-2-yl)amide derivatives as hits for the development of neglected disease drugs.
PMID 19553897·Molecules·2009
7-preclinical
A new scandium metal organic framework built up from octadecasil zeolitic cages as heterogeneous catalyst.
PMID 19377697·Chem Commun (Camb)·2009
8-other
Synthesis, trypanocidal activity and docking studies of novel quinoxaline-N-acylhydrazones, designed as cruzain inhibitors candidates.
PMID 19110434·Bioorg Med Chem·2009
7-preclinical
Structural analysis of zincocenes with substituted cyclopentadienyl rings.
PMID 19065696·Chemistry·2009
8-other
New therapeutic targets for drug design against Trypanosoma cruzi, advances and perspectives.
PMID 19548870·Curr Med Chem·2009
6-review
Efficacy of quinoxaline-2-carboxylate 1,4-di-N-oxide derivatives in experimental tuberculosis.
PMID 18625764·Antimicrob Agents Chemother·2008
7-preclinical
Melanin-concentrating hormone receptor 1 antagonists: a new perspective for the pharmacologic treatment of obesity.
PMID 18393860·Curr Med Chem·2008
6-review
Anti-leishmanial and structure-activity relationship of ring substituted 3-phenyl-1-(1,4-di-N-oxide quinoxalin-2-yl)-2-propen-1-one derivatives.
PMID 19148416·Mem Inst Oswaldo Cruz·2008
7-preclinical
New amide derivatives as melanin-concentrating hormone receptor 1 antagonists for the treatment of obesity.
PMID 19137910·Arzneimittelforschung·2008
7-preclinical
In vitro and in vivo antimycobacterial activities of ketone and amide derivatives of quinoxaline 1,4-di-N-oxide.
PMID 18502817·J Antimicrob Chemother·2008
7-preclinical
[Fallopian tube primary invasive adenocarcinoma associated with acute inflammatory pelvic disease. Case report and literature review].
PMID 18798405·Ginecol Obstet Mex·2008
5-case
Synthesis and preferred all-syn conformation of C3-symmetrical N-(hetero)arylmethyl triindoles.
PMID 18680132·Chemistry·2008
8-other
Resveratrol protects auditory hair cells from gentamicin toxicity.
PMID 18833534·Ear Nose Throat J·2008
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 274 MADISON AVE RM 1500
NEW YORK, NY 10016 - Phone
- (646) 926-3255
Quick Facts
- NPI
- 1619404043
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile